Features and management of poisoning with modern drugs used to treat epilepsy

QJM: An International Journal of Medicine

Volumn 91, Issue 5, 1998, Pages 325-332

  Jones, A L ^a   Proudfoot, A T ^a  

^a NHS LOTHIAN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; ETHOSUXIMIDE; GLUCOSE; LAMOTRIGINE; NALOXONE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

BONE MARROW SUPPRESSION; CARDIOTOXICITY; COMA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; EPILEPSY; FOCAL EPILEPSY; HEMOPERFUSION; HUMAN; HYPERGLYCEMIA; NAUSEA; NEUROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; STOMACH LAVAGE; SUICIDE ATTEMPT; VOMITING;

EID: 0031950227     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.5.325     Document Type: Review

References (113)

1. Manon-Espaillat R, Burnstine TH, Remler B, Reed RC, Osorio I. Antiepileptic drug intoxication: factors and their significance. Epilepsia 1991; 32:96-100.
2. Hawton K, Fagg J, Marsack P. Association between epilepsy and attempted suicide. J Neurol Neurosurg Psychiatr 1980; 43:168-80.
3. Mendez MF, Lanska DJ, Manon-Espaillat R, Burnstine TH. Causative factors for suicide attempts by overdose in epileptics. Arch Neurol 1989; 46:1065-8.
4. Macnab AJ, Birch P, Macready J. Carbamazepine poisoning in children. Pediatr Emerg Care 1993; 9:195-8.
5. Seymour JF. Carbamazepine overdose. Features of 33 cases. Drug Safety 1993; 8:81-8.
6. Morrow JI, Routledge PA. Poisoning by anticonvulsants. Adv Drug React Acute Poisoning Review 1989; 8:97-109.
7. Morselli PL, Frigerio A. Metabolism and pharmacokinetics of carbamazepine. Drug Metab Rev 1975; 4:97-113.
8. Sullivan JB, Rumack BH, Peterson RG. Acute carbamazepine toxicity resulting from overdose. Neurology (NY) 1981; 31:621-4.
9. Coutselinis A, Poulos L. An unusual case of carbamazepine poisoning with near-fatal relapse after two days. Clin Toxicol 1980; 16:385-7.
10. de Zeeuw RA, Westenberg HGM, Van der Kleijn E, Gimbrere JS. An unusual case of carbamazepine poisoning with a near fatal relapse after two days. Clin Toxicol 1979; 14:263-9.
11. Vree TB, Janssen TJ, Hekster YA, Termond EF, van de Dries AC, Wijnands WJ. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose. Ther Drug Monitor 1986; 8:297-304.
12. Gruska H, Beyer KH, Kubucki S, Schneider H. Course, toxicology and therapy of a case of severe carbamazepine poisoning. Arch Toxicol 1971; 27:193-203.
13. Salcman M, Pippenger CE. Acute carbamazepine encephalopathy. JAMA 1975; 231:915.
14. Durelli L, Mutani R, Sechi GP, Monaco F, Glorioso N, Gusmaroli G. Cardiac side effects of phenytoin and carbamazepine: a dose related phenomenon? Arch Neurol 1985; 42:1067-8.
15. Evans RW, Gualtieri CT. Carbamazepine: a neuropsycological and psychiatric profile. Clin Neuropharmacol 1985; 8:221-41.
16. Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbazepine intoxication. Ann Emerg Med 1995; 25:624-30.
17. Todorovic V, Randelovic S, Joksovic D, Jovic-Stosic J, Vucinic S, Glisovic L. Carbamazepine cardiotoxicity in acute poisoning. Vojnosanitetski Pregled 1993; 50:143-6.
18. Parihar PS, Thussu A, Sharma S, Prabhakar S. Carbamazepine induced sino-atrial block in a young adult (letter). J Assoc Physicians India 1996; 44:431-2.
19. Gary NE, Byra WM, Eisinger RP. Carbamazepine poisoning: treatment by haemoperfusion. Nephron 1981; 27:202-3.
20. Leslie PJ, Heyworth R, Prescott LF. Cardiac complications of carbamazepine intoxication: treatment by hemoperfusion. Br Med J 1983; 286:1018.
21. Beerman B, Edhag O, Vallin H. Advanced heart block aggravated by carbamazepine. Br Heart J 1975; 37:668-71.
22. Tsao CY, Wright FS. Acute chemical pancreatitis associated with carbamazepine intoxication. Epilepsia 1993; 34:174-6.
23. Soman M, Swenson C. A possible case of carbamazepine-induced pancreatitis. Drug Intell Clin Pharm 1985; 19:925-7.
24. Forte A, Gallinaro L, Montesano G, Turano R, Bertagni A, Illuminati G. A possible case of carbamazepine induced pancreatitis. Riv Eur Sci Med Farmacol 1996; 18:187-9.
25. Gaudreault P, Parent M, Chicoine L, Lovejoy FH. Carbamazepine overdose in children. Clinical presentation and pharmacodynamics. Vet Hum Toxicol 1984; 26:401.
26. Begley JP. Pulmonary oedema after carbamazepine overdose [letter]. Anaesthesia 1989; 44:789-90.
27. Sharma P, Gupta RC, Bhardwaja B, Mathur AK. Status epilepticus and death following acute carbamazepine poisoning [letter]. J Assoc Physic India 1992; 40:561-2.
28. Patsalos PN, Krishna S, Elyas AA, Lascelles PT. Carbamazepine and carbamazepine-10, 11 -epoxide pharmacokinetics in an overdose patient. Human Toxicol 1987; 6:241-4.
29. Spiller HA, Krenzelok EP, Cookson E. Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol 1990; 28:445-58.
30. Spiller HA, Krenzelok EP. Carbamazepine overdose: serum concentration less predictive in children [letter]. J Toxicol Clin Toxicol 1993; 31:459-60.
31. Montgomery VL, Richman BJ, Goldsmith LJ, Rodgers GC Jr. Severity and carbamazepine level at time of initial poison center contact correlate with outcome in carbamazepine poisoning. Clin Tox 1995; 33:311-23.
32. Hojer J, Malmlund HO, Berg A. Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone. J Toxicol Clin Toxicol 1993; 31:449-58.
33. McAlpine SB, Calabro JJ, Robinson MD, Burkle FM Jr. Late death in tricyclic antidepressant overdose revisited. Ann Emerg Med 1986; 15:1349-52.
34. Lawless L, De Monaco HJ. Acute carbamazepine toxicity resulting from overdose. Neurology 1981 ; 31:621-4.
35. Neuvonen PJ, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17:51-7.
36. Boldy DAR, Heath A, Ruddock S, Vale JA, Prescott LF. Activated charcoal for carbamazepine poisoning. Lancet 1987; 1:1027.
37. Montoya-Cabrera MA, Sauceda-Garcia JM, Escalante-Galindo P, Flores-Alvarez E, Ruiz-Gomez A. Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal (MDAC) in enhancing carbamazepine elimination. Arch Med Res 1996; 27:485-9.
38. Wason S, Baker RC, Carolan P, Seigel R, Druckenbrod RW. Carbamazepine overdose - the effects of multiple dose activated charcoal. J Toxicol Clin Toxicol 1992; 30:39-48.
39. Bradberry SM Vale JA. Multiple-dose activated charcoal: a review of relevant clinical studies. Clin Toxicol 1995; 33:407-16.
40. Bock E, Keller F, Heitz J, Heinemeyer G. Treatment of carbamazepine poisoning by combined hemodialysis/ hemoperfusion. Int J Clin Pharmacol 1989; 27:490-2.
41. Lee CS, Wang LH. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis. Clin Toxicol 1980; 17:429-38.
42. Clancy RR. New anticonvulsants in pediatrics: carbamazepine and valproate. Curr Prob Pediatr 1987; 17:135-209.
43. Kale PB, Thomson PA, Provenzano R, Higgins MJ. Evaluation of plasmapheresis in the treatment of an acute overdose of carbamazepine. Ann Pharmacother 1993; 27:866-70.
44. Goulet JR, Kinkel AW, Smith TC. Metabolism of ethosuximide. Clin Pharmacol Ther 1976; 20:213-18.
45. Buchanan RA, Kinkel AW, Turner JL, Heffelfinger JC. Ethosuximide dose regimens. Clin Pharmacol Ther 1976; 19:143-7.
46. Troupin AS. The measurement of anticonvulsant agent levels. Ann Intern Med 1984; 100:854-8.
47. Heel RC, Avery GS. Appendix A. Drug Data Information. In Avery GS, ed. Drug Treatment. Principles and Practice of Clinical Pharmacology and Therapeutics, 2nd edn. Sydney, Adis Press, 1980:1217.
48. Boehnert M, Lovejoy FH Jr. The effect of phenytoin on cardiac conduction and ventricular arrhythmias in acute tricyclic antidepressant overdose. Abst. Vet Hum Toxicol 1985; 28:285.
49. Katz AA, Hoffman RS, Silverman RA. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med 1993; 22:1485-7.
50. Sacks C. Phenytoin toxicity. In Tintinalli,ed. Emergency medicine: a comprehensive study guide. New York, McGraw-Hill, 1988:698-9.
51. Wilder BJ, Buchanan RA, Serrano EE. Correlation of acute diphenylhydantoin intoxication with plasma levels and metabolic excretion. Neurology 1973; 23:1329-32.
52. Albertson TE, Fisher CJ Jr, Shragg TA, Baselt RC. A prolonged severe intoxication after ingestion of phenytoin and phenobarbital. West J Med 1981; 135:418-22.
53. Garrettson LK, Jusko WJ. Diphenylhydantoin elimination kinetics in overdosed children. Clin Pharmacol Ther 1975; 17:481-91.
54. Mellick LB, Morgan JA, Mellick GA. Presentations of acute phenytoin overdose. Am J Emerg Med 1989; 7:61-7.
55. Murphy JM, Motiwala R, Devinsky O. Phenytoin intoxication. South Med J 1991; 84:1199-204.
56. Teta D, Uldry PA, Regli F. Reversible ophthalmoplegia, cerebellar syndrome and vigilance disorders following phenytoin poisoning. Schweiz Med Wochenschr 1990; 120:1504-7.
57. Manlapaz JS. Abducens nerve palsy in Dilantin intoxication. J Pediatr 1959; 55:73-4.
58. Thurston SE, Leigh J, Abel LA, Dell Osso LF. Slow saccades and hypometria in anticonvulsant toxicity. Neurology 1984; 34:1593-6.
59. Moling JH, Posch JJ. Acute diphenylhydantoin intoxication. Pediatrics 1957; 20:877-80.
60. Nauth-Misir TN. A case of gross overdosage of soluble phenytoin. Br Med J 1948; 2:646.
61. Wilson JT, Huff JG, Kilroy AW. Prolonged toxicity following acute phenytoin overdose in a child. J Pediatr 1979; 95:135-8.
62. Luef G, Burtscher J, Kremser C, Birbamer G, Aichner F, Bauer G, Felber S. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages. Eur Neurol 1996; 36:273-7.
63. Mack RB. Medical exorcision - acute dilantin intoxication. NC Med J 1984; 45:99-100.
64. Wyte CD, Berk WA. Severe oral phenytoin overdose does not cause cardiovascular morbidity. Ann Emerg Med 1991; 20:508-12.
65. Durelli L, Massazza U, Cavallo R. Carbamazepine toxicity and poisoning. Incidence, clinical features and management. Med Toxicol Adv Drug Exp 1989; 4:95-107.
66. Goldberg EM, Sanbar SS. Hyperglycaemic nonketotic coma following administration of Dilantin (diphenylhydantoin). Diabetes 1969; 18:101-6.
67. Stansell PE, Schedewei HK, Elders J, Fiser RH Jr, Bornhofen JH, MacLeod VO. Transient diabetes mellitus secondary to diphenylhydantoin intoxication. J Ark Med Soc 1979; 76:209-10.
68. Manto M, Presier JC, Vincent JL. Hypoglycemia associated with phenytoin intoxication. Clin Tax 1996; 34:205-8.
69. Loscher W, Nau H. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment. J Pharmacol Exp Ther 1983; 226:845-54.
70. Subik M, Robinson DS. Phenytoin overdose with high plasma levels (case report). West Va Med J 1982; 78:781-2.
71. Howard CE, Roberss RS, Ely DS, Moye RA. Use of multiple-dose activated charcoal in phenytoin toxicity. Ann Pharmacother 1994; 28:201-3.
72. Prescott LF, Boye GL, Simpson D. Rapid drug removal after overdosage by gastrointestinal dialysis with activated charcoal. 3rd World Conference on Clinical Pharmacology and Therapeutics, Stockholm, 1986. Abstr II: 270, No 1431.
73. Weidle PJ, Skiest DJ, Forrest A. Multiple-dose activated charcoal as adjunct therapy after chronic phenytoin intoxication. Drug Exp 1991; 10:711-14.
74. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991; 20:648-51.
75. Bosl R, Shideman JR, Meyer RM, Buselmeier TJ, von Hartitzsch B. Effects and complications of high efficiency dialysis. Nephron 1975; 15:151-60.
76. Czajka PA, Anderson WH, Christoph RA, Banner WJ. A pharmacokinetic evaluation of peritoneal dialysis for phenytoin intoxication. J Clin Pharmacol 1980; 20:565-9.
77. Pond SM, Rosenberg J, Benowitz NL, Takki S. Pharmacokinetics of haemoperfusion for drug overdose. Clin Pharmacokinet 1979; 4:329-54.
78. Jacobsen D, Alvik A, Bredesen JE, Brown RD. Pharmacokinetics of phenytoin: Acute intoxication in an adult and in two children. Vet Hum Toxicol 1986; 28:473(Abstract).
79. Larsen LS, Sterrett JR, Whitehead B, Marcus SM. Adjunctive therapy of phenytoin overdose. A case report using plasmapheresis. Clin Toxicol 1986; 24:37-49.
80. Narcy P, Zorza G, Taburet AM, Mersch JM, Devictor D, Huault G. Severe poisoning with intravenous phenytoin in the newborn. Value of peritoneal dialysis. Archives Francaises de Pediatrie 1990; 47:591-3.
81. Godin Y, Heiner L, Mark J, Mandel P. Effects of di-n-propylacetate, an anticonvulsive compound, on GABA metabolism. J Neurochem 1969; 16:869-73.
82. Gugler R, Von Unruh GE. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1980; 5:67-83.
83. Isom JB. On the toxicity of valproic acid. Am J Dis Child 1984; 138:901-3.
84. Dupuis RE, Lichtman SN, Pollack GM. Acute valproic acid overdose - clinical course and pharmacokinetic disposition of valproic acid and metabolites. Drug Safety 1990; 5:65-71.
85. Garnier R, Boudignat O, Fournier PE. Valproate poisoning. Lancet 1982; 2:97.
86. Steinman GS, Woerpel RW, Sherard ES. Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol 1979; 6:274.
87. Duarte J, Macias S, Coria F, Fernandez E, Claveria LE. Valproate-induced coma: case report and literature review. Ann Pharmacother 1993; 27:582-3.
88. Khoo SH, Leyland MJ. Cerebral edema following acute sodium valproate overdose. Clin Toxicol 1992; 30:209-14.
89. Bigler D. Neurological sequelae after intoxication with sodium valproate. Acta Neurolog Scand 1985; 72:351-2.
90. Chadwick D, Reynolds EH, Marsden CD. Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. J Neurol Neurosurg Psychiatr 1976; 39:1210-18.
91. Eeg-Olofsson O, Linskog U. Acute intoxication with valproate. Lancet 1982; 2:1306.
92. Chadwick DW, Cumming WJK, Livingstone I, Cartledge NEF. Acute intoxication with sodium valproate. Ann Neurol 1978; 6:552-3.
93. Van der Merwe AC, Albrecht CF, Brink MS, Coetzee AR. Sodium valproate poisoning: a case report. S Afr Med J 1985; 67:735-6.
94. Howanitz JH, Howanitz PJ, Henry JB, eds. Clinical diagnosis and management by laboratory methods, vol 1, edn 16. WB Saunders, Philadelphia, 1979:477-524.
95. Connacher AA, Macnab MSP, Moody JP, Jung RT. Fatality due to massive overdose of sodium valproate. Scot Med J 1987; 32:85-6.
96. Schnabel R, Rambeck B, Janssen F. Fatal intoxication with sodium valproate. Lancet 1984; 1:221-2.
97. Andersen GO, Ritland S. Life threatening intoxication with sodium valproate. Clin Tox 1995; 33:279-84.
98. Berthelot-Moritz F, Chadda K, Chanavaz I, Leroy JP, Droy JM, Bonmarchand G, Leroy J. Fatal sodium valproate poisoning (letter). Intensive Care Med 1997; 23:599.
99. Farrar HC, Herold DA, Reed MD. Acute valproic acid intoxication: enhanced drug clearance with oral activated charcoal. Crit Care Med 1993; 21:299-301.
100. Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D. Central nervous system manifestations of a valproic acid overdose responsive to naloxone. Ann Emerg Med 1989; 18:889-91.
101. Mortensen PB, Hansen HE, Pedersen B, Hartmann-Andersen F, Husted SE. Acute valproate intoxication: Biochemical investigations and haemodialysis treatment, Int J Clin Pharmacol Ther Toxicol 1983; 21:64-8.
102. Zaccara C, Messori A, Moroni F. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1988; 15:367-89.
103. Tank JE, Palmer BF. Simultaneous 'In Series' haemodialysis and haemoperfusion in the management of valproic acid overdose. Am J Kid Dis 1993; 22:341 -4.
104. Leach MJ, Marsden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II. Neurochemical studies of the mechanism of action. Epilepsia 1986; 27:490-7.
105. Brodie MJ. Lamotrigine. Lancet 1992; 339:1397-400.
106. Buckley NA, Whyte IM, Dawson AH. Self-poisoning with lamotrigine (letter). Lancet 1993; 342:1552-3.
107. Sabers A, Gram L. Pharmacology of vigabatrin. Pharmacol Toxicol 1992; 70:237-43.
108. Vigabatrin (editorial). Lancet 1989; i:532-3.
109. Schechter PJ, Hanke NF, Grove J, Huebert N, Sjoerdsma A. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy. Neurol 1984; 34:182-6.
110. Davie MB, Cook MJ, Ng C. Vigabatrin overdose (letter). Med J Aust 1996; 165:403.
111. Thomson AH, Brodie MJ. Pharmacokinetic optimisation of anticonvulsant treatment. Clin Pharmacokinet 1992; 23:216-30.
112. Clinical Investigator Bureau. Vigabatrin (CABA transaminase inhibitor). Merrell Dow Research Institute. Cincinnati, Merrell Dow Pharmaceuticals, 1988
113. Sander JW, Hart YM, Trimble MR, Shorvon SD. Vigabatrin and psychosis. J Neurol Neurosurg Psychiatr 1991; 54:435-9.